Ampio Accounts Payable vs Gross Profit Analysis

AMPE Stock  USD 0.82  0.01  1.23%   
Ampio Pharm financial indicator trend analysis is way more than just evaluating Ampio Pharm prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ampio Pharm is a good investment. Please check the relationship between Ampio Pharm Accounts Payable and its Gross Profit accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ampio Pharm. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade Ampio Stock refer to our How to Trade Ampio Stock guide.

Accounts Payable vs Gross Profit

Accounts Payable vs Gross Profit Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ampio Pharm Accounts Payable account and Gross Profit. At this time, the significance of the direction appears to have very week relationship.
The correlation between Ampio Pharm's Accounts Payable and Gross Profit is 0.26. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Gross Profit in the same time period over historical financial statements of Ampio Pharm, assuming nothing else is changed. The correlation between historical values of Ampio Pharm's Accounts Payable and Gross Profit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Ampio Pharm are associated (or correlated) with its Gross Profit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Gross Profit has no effect on the direction of Accounts Payable i.e., Ampio Pharm's Accounts Payable and Gross Profit go up and down completely randomly.

Correlation Coefficient

0.26
Relationship DirectionPositive 
Relationship StrengthVery Weak

Accounts Payable

An accounting item on the balance sheet that represents Ampio Pharm obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Ampio Pharm are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Ampio Pharm minus its cost of goods sold. It is profit before Ampio Pharm operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.
Most indicators from Ampio Pharm's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ampio Pharm current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ampio Pharm. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade Ampio Stock refer to our How to Trade Ampio Stock guide.The current year's Enterprise Value Multiple is expected to grow to 0.26, whereas Selling General Administrative is forecasted to decline to about 6.6 M.
 2021 2022 2023 2024 (projected)
Research Development11.9M8.9M2.4M2.3M
Cost Of Revenue1.1M2.1M1.9M3.5M

Ampio Pharm fundamental ratios Correlations

-0.030.580.840.180.840.01-0.54-0.260.130.03-0.150.710.29-0.950.590.970.970.970.090.210.18-0.060.750.560.34
-0.030.75-0.36-0.61-0.04-0.160.10.480.570.610.2-0.320.570.080.12-0.05-0.05-0.02-0.050.2-0.150.52-0.340.37-0.48
0.580.750.25-0.370.52-0.15-0.210.150.480.45-0.040.210.59-0.470.450.520.520.550.010.48-0.080.320.240.59-0.07
0.84-0.360.250.320.630.11-0.33-0.62-0.01-0.52-0.130.640.06-0.830.150.840.840.840.130.220.2-0.590.970.240.42
0.18-0.61-0.370.320.330.31-0.43-0.37-0.9-0.290.140.61-0.78-0.140.140.130.130.09-0.01-0.47-0.06-0.250.23-0.150.84
0.84-0.040.520.630.330.08-0.77-0.09-0.080.15-0.280.810.24-0.640.770.670.670.670.070.250.10.080.530.720.58
0.01-0.16-0.150.110.310.08-0.25-0.22-0.3-0.19-0.20.34-0.150.02-0.17-0.02-0.02-0.030.76-0.160.08-0.180.02-0.230.27
-0.540.1-0.21-0.33-0.43-0.77-0.25-0.140.24-0.230.44-0.85-0.150.39-0.72-0.4-0.4-0.37-0.380.22-0.07-0.21-0.12-0.47-0.47
-0.260.480.15-0.62-0.37-0.09-0.22-0.140.230.74-0.13-0.310.350.290.46-0.31-0.31-0.31-0.1-0.14-0.150.76-0.660.35-0.42
0.130.570.48-0.01-0.9-0.08-0.30.240.230.22-0.11-0.380.87-0.16-0.020.180.180.210.00.430.160.150.040.33-0.73
0.030.610.45-0.52-0.290.15-0.19-0.230.740.220.02-0.080.350.040.63-0.03-0.03-0.03-0.1-0.08-0.090.99-0.590.44-0.25
-0.150.2-0.04-0.130.14-0.28-0.20.44-0.13-0.110.02-0.42-0.340.08-0.31-0.07-0.07-0.07-0.57-0.340.160.01-0.050.01-0.07
0.71-0.320.210.640.610.810.34-0.85-0.31-0.38-0.08-0.42-0.08-0.590.530.60.60.590.41-0.050.11-0.110.470.230.72
0.290.570.590.06-0.780.24-0.15-0.150.350.870.35-0.34-0.08-0.240.280.260.260.290.220.430.170.270.030.59-0.58
-0.950.08-0.47-0.83-0.14-0.640.020.390.29-0.160.040.08-0.59-0.24-0.45-1.0-1.0-0.99-0.1-0.07-0.180.11-0.75-0.38-0.18
0.590.120.450.150.140.77-0.17-0.720.46-0.020.63-0.310.530.28-0.450.450.450.44-0.090.05-0.10.610.040.720.27
0.97-0.050.520.840.130.67-0.02-0.4-0.310.18-0.03-0.070.60.26-1.00.451.01.00.090.130.19-0.110.770.420.2
0.97-0.050.520.840.130.67-0.02-0.4-0.310.18-0.03-0.070.60.26-1.00.451.01.00.090.130.19-0.110.770.420.2
0.97-0.020.550.840.090.67-0.03-0.37-0.310.21-0.03-0.070.590.29-0.990.441.01.00.090.170.2-0.120.780.430.19
0.09-0.050.010.13-0.010.070.76-0.38-0.10.0-0.1-0.570.410.22-0.1-0.090.090.090.09-0.030.11-0.110.0-0.250.02
0.210.20.480.22-0.470.25-0.160.22-0.140.43-0.08-0.34-0.050.43-0.070.050.130.130.17-0.030.03-0.140.360.240.02
0.18-0.15-0.080.2-0.060.10.08-0.07-0.150.16-0.090.160.110.17-0.18-0.10.190.190.20.110.03-0.110.170.09-0.06
-0.060.520.32-0.59-0.250.08-0.18-0.210.760.150.990.01-0.110.270.110.61-0.11-0.11-0.12-0.11-0.14-0.11-0.660.37-0.25
0.75-0.340.240.970.230.530.02-0.12-0.660.04-0.59-0.050.470.03-0.750.040.770.770.780.00.360.17-0.660.20.38
0.560.370.590.24-0.150.72-0.23-0.470.350.330.440.010.230.59-0.380.720.420.420.43-0.250.240.090.370.20.02
0.34-0.48-0.070.420.840.580.27-0.47-0.42-0.73-0.25-0.070.72-0.58-0.180.270.20.20.190.020.02-0.06-0.250.380.02
Click cells to compare fundamentals

Ampio Pharm Account Relationship Matchups

Ampio Pharm fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets14.0M22.9M38.8M13.6M5.7M5.4M
Other Current Liab3.9M1.4M4.4M755K2.1M1.5M
Total Current Liabilities4.3M1.8M5.1M1.2M2.4M2.6M
Total Stockholder Equity6.4M17.5M27.3M11.8M3.4M3.2M
Retained Earnings(184.6M)(200.5M)(217.6M)(233.9M)(242.5M)(230.4M)
Non Current Assets Total5.8M4.4M3.2M259K297.9K283.0K
Common Stock Total Equity11.1K16K19K23K26.5K27.8K
Common Stock Shares Outstanding474.0K595.4K671.5K753.6K810.1K889.4K
Liabilities And Stockholders Equity14.0M22.9M38.8M13.6M5.7M5.4M
Other Stockholder Equity191.1M218.0M244.9M245.7M245.9M135.4M
Total Liab7.6M5.4M11.5M1.8M2.4M2.3M
Common Stock16K19K23K2K1.8K1.7K
Net Debt(5.1M)(16.1M)(33.0M)(12.0M)(3.8M)(4.0M)
Accounts Payable151K186K427K97K111.6K106.0K
Cash6.5M17.3M33.9M12.7M4.1M3.9M
Cash And Short Term Investments6.5M17.3M33.9M12.7M4.1M3.9M
Total Current Assets8.3M18.5M35.6M13.3M5.7M5.4M
Other Current Assets556K696K533K623K1.6M1.7M
Other Liab2.1M2.6M5.8M333K383.0K363.8K
Net Tangible Assets6.4M17.5M27.3M11.8M10.6M12.4M
Property Plant And Equipment Net5.8M4.4M3.2M259K297.9K283.0K
Retained Earnings Total Equity(171.0M)(184.6M)(200.5M)(217.6M)(195.8M)(186.0M)
Non Current Liabilities Total3.3M3.5M6.4M607K698.1K663.1K
Capital Surpluse176.2M191.1M218.0M244.9M281.6M170.7M
Deferred Long Term Liab7.4M2.1M2.6M5.8M6.7M7.1M
Property Plant And Equipment Gross5.8M4.4M3.2M9.5M10.9M5.9M
Property Plant Equipment4.7M3.6M2.6M259K297.9K283.0K
Net Invested Capital6.4M17.5M27.3M11.8M13.6M14.2M
Net Working Capital4.0M16.7M30.5M12.1M14.0M13.6M

Pair Trading with Ampio Pharm

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ampio Pharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ampio Pharm will appreciate offsetting losses from the drop in the long position's value.

Moving together with Ampio Stock

  0.62MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr

Moving against Ampio Stock

  0.6DNTH Dianthus Therapeutics Symbol ChangePairCorr
  0.53MDWD Mediwound Financial Report 4th of June 2024 PairCorr
  0.53MESO Mesoblast TrendingPairCorr
  0.47MRK Merck Company Fiscal Quarter End 31st of March 2024 PairCorr
  0.44TCRX Tscan Therapeutics Financial Report 8th of May 2024 PairCorr
The ability to find closely correlated positions to Ampio Pharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ampio Pharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ampio Pharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ampio Pharm to buy it.
The correlation of Ampio Pharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ampio Pharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ampio Pharm moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ampio Pharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Ampio Pharm is a strong investment it is important to analyze Ampio Pharm's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ampio Pharm's future performance. For an informed investment choice regarding Ampio Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ampio Pharm. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade Ampio Stock refer to our How to Trade Ampio Stock guide.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for Ampio Stock analysis

When running Ampio Pharm's price analysis, check to measure Ampio Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ampio Pharm is operating at the current time. Most of Ampio Pharm's value examination focuses on studying past and present price action to predict the probability of Ampio Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ampio Pharm's price. Additionally, you may evaluate how the addition of Ampio Pharm to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Fundamental Analysis
View fundamental data based on most recent published financial statements
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Is Ampio Pharm's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ampio Pharm. If investors know Ampio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ampio Pharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(11.70)
Return On Assets
(0.47)
Return On Equity
(0.92)
The market value of Ampio Pharm is measured differently than its book value, which is the value of Ampio that is recorded on the company's balance sheet. Investors also form their own opinion of Ampio Pharm's value that differs from its market value or its book value, called intrinsic value, which is Ampio Pharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ampio Pharm's market value can be influenced by many factors that don't directly affect Ampio Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ampio Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ampio Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ampio Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.